XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Stockholders Equity - USD ($)
Total
Common stock [Member]
Additional paid-in capital [Member]
Accumulated other comprehensive loss [Member]
Accumulated deficit [Member]
Beginning balance (in shares) at Dec. 31, 2017   6,047,161      
Beginning balance at Dec. 31, 2017 $ 13,292,783 $ 605 $ 25,541,210 $ (18,080) $ (12,230,952)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 9,124   9,124    
Net proceeds from issuance of common stock and warrants (in shares)   375,000      
Net proceeds from issuance of common stock and warrants $ 1,037,764 $ 37 1,037,727    
Issuance of common stock via public offering, net (in shares) 375,000 5,000,000      
Issuance of common stock via public offering, net $ 9,160,048 $ 500 9,159,548    
Net loss (7,665,617)       (7,665,617)
Foreign currency translation adjustments (13,746)     (13,746)  
Ending balance (in shares) at Mar. 31, 2018   11,422,161      
Ending balance at Mar. 31, 2018 15,820,356 $ 1,142 35,747,609 (31,826) (19,896,569)
Beginning balance (in shares) at Dec. 31, 2018   11,422,161      
Beginning balance at Dec. 31, 2018 6,726,620 $ 1,143 35,791,972 (96,728) (28,969,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 97,968   97,968    
Issuance of common stock via public offering, net (in shares) 0        
Net loss $ (3,051,840)       (3,051,840)
Foreign currency translation adjustments 7,621     7,621  
Ending balance (in shares) at Mar. 31, 2019   11,422,161      
Ending balance at Mar. 31, 2019 $ 3,780,369 $ 1,143 $ 35,889,940 $ (89,107) $ (32,021,607)